Post-Brexit MHRA Will Embrace Medtech ‘Innovation Pull’ In The UK
Global device networker role, regulatory agility and patient safety prioritized in new chapter for UK regulator
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.
